The posting, in Isomorphic Labs's own words
archived Nov 6, 2026Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery. Come and be part of an interdisciplinary team driving groundbreaking innovation and play a meaningful role in contributing towards us achieving our ambitious goals, while being a part of an inspiring and collaborative culture. The world we want tomorrow is the one we’re building today. It starts with the culture at this company. It starts with you.
About Iso
Isomorphic Labs (IsoLabs) was launched in 2021 to advance human health by building on and beyond the Nobel-winning AlphaFold system. Since then, our interdisciplinary team of drug discovery experts and machine learning specialists has built powerful new predictive and generative AI models that accelerate scientific discovery at digital speed. Our name comes from the belief that there is an underlying symmetry between biology and information science. By harnessing AI’s powerful capabilities, we can use it to model complex biological phenomena to help design novel molecules, anticipate how drugs will perform and develop innovative medicines to treat and cure some of the world’s most devastating diseases. We have built a world-leading drug design engine comprising AI models that are capable of working across multiple therapeutic areas and drug modalities. We are continually innovating on model architecture and developing cutting-edge capabilities to advance rational drug design. Every day, and with each new breakthrough, we’re getting closer to the promise of digital biology, and achieving our ambitious mission to one day solve all disease with the help of AI.
Read the full posting ↓
About the Exploratory Sciences Team
You will be joining the expanding “Exploratory Sciences” team, focused on tackling proteins which are critical for disease biology, but have been traditionally considered intractable. We are a multidisciplinary team within the Drug Design and Medical Research function at Isomorphic Labs. We work where , chemical biology and drug discovery meet, applying the Isomorphic Labs platform to some of the hardest problems in the field. Our work goes beyond individual targets. We explore emerging therapeutic modalities, molecular glues and peptides to modalities that don't have a playbook yet. We also design the data generation strategies that make these modalities workable for AI-driven design. The experiments we run don't just move drug-discovery programmes forward - they shape the models that power Iso's drug design engine. We're as comfortable in silico as we are at the bench. Our scientists build and test hypotheses computationally, use -based in their daily science, and work alongside ML researchers and engineers on Platform builds. We work closely with teams across Isomorphic Labs, so ideas move quickly from model to real world experiments and back again, keeping the goal of drug discovery and development front and centre. Above all, we're curious and ambitious, and we care about growth. We put continuous learning and development first, because we're building the next generation of drug discovery scientists. If you want to help define what drug discovery looks like next, you'll fit right in.